Wellbutrin XL is a 24-Hour Extended-Release Formulation Only
Wellbutrin XL 150 mg is exclusively a 24-hour extended-release formulation designed for once-daily morning administration; there is no 12-hour extended-release version of Wellbutrin XL. 1
Formulation Distinctions
Wellbutrin XL is the extended-release formulation that delivers medication over 24 hours with once-daily dosing, typically administered in the morning. 2, 1
Wellbutrin SR (sustained-release) is a different formulation that requires twice-daily dosing approximately 12 hours apart, with the second dose taken before 3 PM to minimize insomnia risk. 3, 2
The XL and SR formulations are not interchangeable in their dosing schedules despite delivering comparable total daily exposure at equivalent doses—each must follow its specific FDA-approved timing to maintain safety and efficacy. 2
Pharmacokinetic Profile of Wellbutrin XL
Following oral administration of Wellbutrin XL, the time to peak plasma concentration (Tmax) for bupropion is approximately 5 hours, reflecting its extended-release design. 1, 4
This contrasts with the SR formulation, which has a Tmax of approximately 3 hours, and the immediate-release formulation with a Tmax of approximately 1.5 hours. 4
Steady-state plasma concentrations are reached within 8 days of once-daily XL dosing. 1
Bioequivalence Studies
Wellbutrin XL 300 mg once daily has been demonstrated to be bioequivalent to both the immediate-release formulation at 100 mg three times daily and the sustained-release formulation at 150 mg twice daily, with similar peak plasma concentrations and area under the curve for bupropion and its three active metabolites. 1
Despite this bioequivalence in total exposure, the formulations differ in their release kinetics and must be dosed according to their specific schedules. 4
Clinical Prescribing Data
In a large real-world analysis of 766,100 patients initiating bupropion treatment, the extended-release 24-hour 150 mg formulation (Wellbutrin XL) was the most commonly prescribed, accounting for 62% of all bupropion initiations. 5
This predominance reflects both the convenience of once-daily dosing and the reduced insomnia risk compared to formulations requiring afternoon or evening doses. 2
Dosing Recommendations for XL Formulation
The standard initiation protocol for Wellbutrin XL is 150 mg once daily in the morning, with potential titration to 300 mg once daily after 4 days if tolerated. 2
The maximum recommended dose for Wellbutrin XL is 450 mg per day, administered as a single morning dose. 3, 1
Morning administration is essential to align with the 24-hour release profile and minimize sleep disturbance from the medication's activating properties. 2
Common Prescribing Error to Avoid
Clinicians should not attempt to split Wellbutrin XL dosing into twice-daily administration, as this defeats the purpose of the extended-release formulation and may increase adverse effects, particularly insomnia. 2
If twice-daily dosing is clinically preferred, the appropriate choice is Wellbutrin SR (sustained-release), not XL. 3, 2